News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medtronic, Inc. (MDT) Rejected by U.S. High Court on Edwards Lifesciences Corporation (EW) Valve Patent


10/8/2013 7:52:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

The U.S. Supreme Court left intact a patent ruling that may cost a Medtronic Inc. (MDT:US) unit more than $200 million in its clash with Edwards Lifesciences Corp. (EW:US) over devices that repair aortic valves without open-heart surgery. The justices today turned away an appeal from Medtronic’s CoreValve unit, which a jury concluded infringed an Edwards heart-valve patent. A lower court upheld the jury’s $74 million verdict in November.

Help employers find you! Check out all the jobs and post your resume.

Read at BusinessWeek


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES